Stay updated on IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Sign up to get notified when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.

Latest updates to the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check20 days agoChange DetectedA notice was added explaining that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference0.8%

- Check27 days agoChange DetectedThe website footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov site footer now displays revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check54 days agoChange DetectedA new revision entry labeled v3.7.0 has been added to the Record History, and the previous revision v3.6.6 was removed from the list.SummaryDifference0.1%

- Check75 days agoChange DetectedA new study record version, Revision: v3.6.6, was added to the history. The previous version, Revision: v3.6.5, was removed from the sequence.SummaryDifference0.1%

Stay in the know with updates to IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.